AEterna Zentaris Inc. (AEZS)

[Miraclestock]

Strongbridge BioPharma (SBBP) which licenses Macrilen from Aterna Zentaris (AEZS) in the USA and Canada is doing another stock offering. This time for 9,000,000-10,500,500 shares. Makes you wonder why. They already have 92 million cash on hand. In addition, to the 92 million cash on hand, SBBP is now beginning to make money from Macrilen sales in USA and Canada. Is it possible that SBBP could be looking to buyout AEZS with the money raise right after Macrilen is approved in Europe? I always thought SBBP was the perfect company to buyout AEZS. It makes you wonder why the share offering now so close to Macrilen approval in Europe. Just a thought.